心脏磁共振成像在评估肿瘤相关性心脏毒性中的应用。
Cardiac MRI for the evaluation of oncologic cardiotoxicity.
机构信息
Department of Medicine, Cardiovascular Medicine Division, University of Virginia Health System, 1215 Lee Street, PO Box 800158, Charlottesville, VA, 22908, USA.
Department of Biomedical Engineering, University of Virginia Health System, Charlottesville, VA, USA.
出版信息
J Nucl Cardiol. 2018 Dec;25(6):2148-2158. doi: 10.1007/s12350-018-1293-9. Epub 2018 May 7.
Abstract
Cancer therapeutics-related cardiac dysfunction (CTRCD) is a well-established adverse effect resulting from a number of cancer therapeutics. Newer immunotherapy has been associated with cardiomyopathy and myocarditis making comprehensive imaging useful for early recognition. Cardiac MRI (CMR) offers a comprehensive evaluation to detect CTRCD. Established guidelines for monitoring left ventricular ejection fraction for potential cardiotoxicity have recently incorporated CMR. We will review the utility of CMR in contemporary evaluation for potential oncologic cardiotoxicity.
摘要
癌症治疗相关的心脏功能障碍（CTRCD）是许多癌症治疗方法所产生的一种公认的不良反应。新型免疫疗法与心肌病和心肌炎有关，因此全面的影像学检查对于早期识别很有用。心脏磁共振成像（CMR）可提供全面的评估以检测 CTRCD。最近，用于监测潜在心脏毒性的左心室射血分数的既定指南已纳入 CMR。我们将回顾 CMR 在潜在肿瘤性心脏毒性的当代评估中的应用。
相似文献
1
Cardiac MRI for the evaluation of oncologic cardiotoxicity.心脏磁共振成像在评估肿瘤相关性心脏毒性中的应用。
J Nucl Cardiol. 2018 Dec;25(6):2148-2158. doi: 10.1007/s12350-018-1293-9. Epub 2018 May 7.
2
Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.连续心血管磁共振应变测量识别乳腺癌心脏毒性：与超声心动图比较。
JACC Cardiovasc Imaging. 2021 May;14(5):962-974. doi: 10.1016/j.jcmg.2020.09.039. Epub 2020 Nov 25.
3
Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.核医学在多模态成像中用于检测癌症治疗药物引起的心脏毒性：已建立和新兴的方法。
J Nucl Cardiol. 2020 Aug;27(4):1210-1224. doi: 10.1007/s12350-019-01671-6. Epub 2019 Mar 13.
4
Myocardial injury detected by T1 and T2 mapping on CMR predicts subsequent cancer therapy-related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided RT.CMR 上 T1 和 T2 映射检测到的心肌损伤可预测接受表阿霉素为基础的化疗或左侧 RT 治疗的乳腺癌患者随后发生与癌症治疗相关的心脏功能障碍。
Eur Radiol. 2022 Mar;32(3):1853-1865. doi: 10.1007/s00330-021-08260-7. Epub 2021 Sep 18.
5
Improving reproducibility of left ventricular ejection fraction in pediatric oncology patients: less is more.提高儿科肿瘤患者左心室射血分数的可重复性：少即是多。
Int J Cardiovasc Imaging. 2020 Oct;36(10):1887-1895. doi: 10.1007/s10554-020-01901-w. Epub 2020 Jun 2.
6
Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.心脏磁共振成像在免疫检查点抑制剂相关性心脏毒性中心肌应变和组织特征的研究。
PLoS One. 2021 Feb 19;16(2):e0246764. doi: 10.1371/journal.pone.0246764. eCollection 2021.
7
The association of reduced global longitudinal strain with cancer therapy-related cardiac dysfunction among patients receiving cancer therapy.癌症治疗患者中，整体纵向应变降低与癌症治疗相关的心脏功能障碍的相关性。
Clin Res Cardiol. 2020 Feb;109(2):255-262. doi: 10.1007/s00392-019-01508-9. Epub 2019 Jun 18.
8
Contemporary Role of Echocardiography for Clinical Decision Making in Patients During and After Cancer Therapy.超声心动图在癌症治疗期间和治疗后患者临床决策中的当代作用。
JACC Cardiovasc Imaging. 2018 Aug;11(8):1122-1131. doi: 10.1016/j.jcmg.2018.03.025.
9
Can global longitudinal strain (GLS) with magnetic resonance prognosticate early cancer therapy-related cardiac dysfunction (CTRCD) in breast cancer patients, a prospective study?磁共振整体纵向应变（GLS）能否预测乳腺癌患者早期癌症治疗相关心脏功能障碍（CTRCD）？一项前瞻性研究
Magn Reson Imaging. 2023 Apr;97:68-81. doi: 10.1016/j.mri.2022.12.015. Epub 2022 Dec 26.
10
Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity.超声心动图和 MRI 在癌症治疗性心脏毒性检测中的变异性。
Heart. 2020 Jun;106(11):817-823. doi: 10.1136/heartjnl-2019-316297. Epub 2020 Feb 25.
引用本文的文献
1
Significant Reduction in Peak Left Ventricular Global Longitudinal Strain in Multiple Myeloma Patients: A Pilot Random Awareness Analysis.多发性骨髓瘤患者左心室整体纵向应变峰值显著降低：一项初步随机认知分析
Cureus. 2025 Mar 13;17(3):e80509. doi: 10.7759/cureus.80509. eCollection 2025 Mar.
2
Chemotherapy Related Cardiotoxicity Evaluation-A Contemporary Review with a Focus on Cardiac Imaging.化疗相关心脏毒性评估——聚焦心脏成像的当代综述
J Clin Med. 2024 Jun 26;13(13):3714. doi: 10.3390/jcm13133714.
3
EGFR-TKIs - induced cardiotoxicity in NSCLC: incidence, evaluation, and monitoring.表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKIs）诱导的非小细胞肺癌心脏毒性：发生率、评估及监测
Front Oncol. 2024 Jun 24;14:1426796. doi: 10.3389/fonc.2024.1426796. eCollection 2024.
4
Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy.新型功能放射组学预测肺癌放疗中心脏正电子发射断层扫描摄取率。
JCO Clin Cancer Inform. 2024 Mar;8:e2300241. doi: 10.1200/CCI.23.00241.
5
Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report.奥希替尼诱发的双心室心肌病伴心脏磁共振成像异常表现：一例报告
Cardiooncology. 2023 Oct 31;9(1):38. doi: 10.1186/s40959-023-00190-1.
6
Impact of Cancer Type and Treatment Protocol on Cardiac Function in Pediatric Oncology Patients: An Analysis Utilizing Speckle Tracking, Global Longitudinal Strain, and Myocardial Performance Index.癌症类型和治疗方案对儿科肿瘤患者心脏功能的影响：一项利用斑点追踪、整体纵向应变和心肌性能指数的分析
Diagnostics (Basel). 2023 Aug 31;13(17):2830. doi: 10.3390/diagnostics13172830.
7
Role of advanced cardiovascular imaging in chemotherapy-induced cardiotoxicity.先进心血管成像在化疗所致心脏毒性中的作用
Heliyon. 2023 Apr 5;9(4):e15226. doi: 10.1016/j.heliyon.2023.e15226. eCollection 2023 Apr.
8
Commentary: "Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data".评论：“用于癌症治疗相关心脏毒性早期检测与监测的多模态先进心血管和分子成像以及人工智能和大数据的作用”
Front Cardiovasc Med. 2023 Feb 27;10:982028. doi: 10.3389/fcvm.2023.982028. eCollection 2023.
9
Imaging assessment of toxicity related to immune checkpoint inhibitors.免疫检查点抑制剂相关毒性的影像学评估。
Front Immunol. 2023 Feb 23;14:1133207. doi: 10.3389/fimmu.2023.1133207. eCollection 2023.
10
Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM).核医学在评估和预防癌症治疗相关的心脏毒性方面的应用：欧洲核医学协会（EANM）的应用前景和建议。
Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):792-812. doi: 10.1007/s00259-022-05991-7. Epub 2022 Nov 5.
本文引用的文献
1
Early Myocardial Strain Changes During Potentially Cardiotoxic Chemotherapy May Occur as a Result of Reductions in Left Ventricular End-Diastolic Volume: The Need to Interpret Left Ventricular Strain With Volumes.潜在心脏毒性化疗期间早期心肌应变变化可能是左心室舒张末期容积减少的结果：需结合容积解读左心室应变。
Circulation. 2017 Jun 20;135(25):2575-2577. doi: 10.1161/CIRCULATIONAHA.117.027930.
2
Recent Advances in Cardiovascular Magnetic Resonance: Techniques and Applications.心血管磁共振成像的最新进展：技术与应用
Circ Cardiovasc Imaging. 2017 Jun;10(6). doi: 10.1161/CIRCIMAGING.116.003951.
3
MRI-Derived Myocardial Strain Measures in Normal Subjects.正常受试者的 MRI 衍生心肌应变测量
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):196-205. doi: 10.1016/j.jcmg.2016.12.025. Epub 2017 May 17.
4
Feature Tracking by CMR: A "Double Feature"?心脏磁共振成像的特征追踪：“双重特征”？
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):206-208. doi: 10.1016/j.jcmg.2017.01.024. Epub 2017 May 17.
5
Short and long term radiation induced cardiovascular disease in patients with cancer.癌症患者的短期和长期辐射诱发心血管疾病
Clin Cardiol. 2017 Apr;40(4):255-261. doi: 10.1002/clc.22634. Epub 2017 Jan 31.
6
Fulminant Myocarditis with Combination Immune Checkpoint Blockade.暴发性心肌炎合并免疫检查点阻断治疗
N Engl J Med. 2016 Nov 3;375(18):1749-1755. doi: 10.1056/NEJMoa1609214.
7
Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.蒽环类药物相关的T1映射特征升高，与癌症幸存者心血管合并症的存在无关。
Circ Cardiovasc Imaging. 2016 Aug;9(8). doi: 10.1161/CIRCIMAGING.115.004325.
8
Myocardial T2 Mapping Increases Noninvasive Diagnostic Accuracy for Biopsy-Proven Myocarditis.心肌T2成像提高了经活检证实的心肌炎的无创诊断准确性。
JACC Cardiovasc Imaging. 2016 Dec;9(12):1467-1469. doi: 10.1016/j.jcmg.2015.11.014. Epub 2016 Apr 13.
9
T1 Mapping: Basic Techniques and Clinical Applications.T1 映射：基本技术与临床应用。
JACC Cardiovasc Imaging. 2016 Jan;9(1):67-81. doi: 10.1016/j.jcmg.2015.11.005.
10
Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.霍奇金淋巴瘤治疗后的心血管疾病：对九项欧洲癌症研究与治疗组织-淋巴瘤研究协会协作试验的分析
Lancet Haematol. 2015 Nov;2(11):e492-502. doi: 10.1016/S2352-3026(15)00153-2. Epub 2015 Oct 22.
Zotero 插件